Briacell Therapeutics Corp share price logo

Briacell Therapeutics Corp Share Price

NASDAQ: BCTXZ

$0.15

+0.01

(+11.11%)

as on

Briacell Therapeutics Corp Stock Performance

as on April 11, 2026 at 6:58 am IST

  • Day's Low

    $0.14
    $0.15
    downward going graph

    6.67%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.06
    $1.52
    downward going graph

    63.27%

    Downside

    910.00%

    Upside

    downward going graph

Briacell Therapeutics Corp share price movements today

Previous Close
$0.14
Open
$0.14
Volume
278.4K
Day's Low - High
$0.14 - $0.15
52 Week Low - High
$0.06 - $1.52

Briacell Therapeutics Corp Historical Returns

1 Month Return
+ 3.45 %
3 Month Return
-44.44 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Briacell Therapeutics Corp Stock Fundamentals & Key Indicators

Check Briacell Therapeutics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-179.21%

Briacell Therapeutics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Briacell Therapeutics Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Briacell Therapeutics Corp image
Briacell Therapeutics Corp
NA$-NANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$33.4B388.36%-16.34-210.54%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.6B133.02%140.918.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$113.6B104.49%29.1632.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$81.2B57.6%18.5231.41%

Briacell Therapeutics Corp Stock’s Investor Sentiment and Interest

Search interest for Briacell Therapeutics Corp Stock has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:25% versus previous 30 day period

Briacell Therapeutics Corp Quarterly Profit & Loss

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Oct 2025
Jan 2026
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
0
0
Operating Income
-9
-9
-5
-5
-7
-6
-11
-7
EBITDA
-9
-9
-5
-5
-7
-6
-11
-7
Interest Expense
-
-
-
-
-
0
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-11
1
-1
-5
-6
-6
-11
-7
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-11
1
-1
-5
-6
-6
-11
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Briacell Therapeutics Corp Annual Profit & Loss

All numbers in Millions USD

Jul 2021
Jul 2022
Jul 2023
Jul 2024
Total Revenue
-
-
-
-
Gross Profit
0
0
0
0
Operating Income
-6
-15
-23
0
EBITDA
-6
-34
-27
0
Interest Expense
0
0
-
-
Depreciation
0
0
0
0
Income Before Tax
-13
-26
-20
0
Income Tax Expense
6
0
0
-
Net Income
-2
-11
-20
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Briacell Therapeutics Corp Quarterly Cash Flow

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Net Income
-11
1
-1
-5
-6
-6
-8
-8
-7
Operating Cash Flow
-7
-5
-4
-6
-5
-7
-8
-10
-8
Investing Cash Flow
-
0
0
0
0
0
-7
0
7
Financing Cash Flow
-
-
4
11
5
14
13
-
28
Change in Cash
-7
-5
0
4
0
7
-1
-10
26

Briacell Therapeutics Corp Annual Cash Flow

All numbers in Millions USD

Jul 2017
Jul 2018
Jul 2019
Jul 2020
Jul 2021
Jul 2022
Jul 2023
Jul 2024
Jul 2025
Net Income
-2
-4
-4
-3
0
-26
-20
-4
-26
Operating Cash Flow
-1
-3
-3
-1
-7
-12
-23
-24
-28
Investing Cash Flow
0
0
1
-
-
-
-
0
-7
Financing Cash Flow
2
4
2
1
64
-3
3
4
45
Change in Cash
0
0
0
0
57
-16
-19
-20
9

Insights on Briacell Therapeutics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BCTXZ stock has moved down by -26.4%

About Briacell Therapeutics Corp

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.
OrganisationBriacell Therapeutics Corp
HeadquartersBellevue Centre, West Vancouver, BC, Canada, V7T 2X1
CEODr. William V. Williams FCPA, M.D.
E-voting on sharesClick here to vote

Key Management of Briacell Therapeutics Corp

Name

Title

Dr. Giuseppe Del Priore M.D., M.P.H.

Chief Medical Officer

Dr. Charles Louis Wiseman FACP, M.D.

Founder, Principal Research Advisor & Member of Scientific Advisory Board

Dr. William V. Williams FCPA, M.D.

CEO, President & Director

Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.

CFO & Corporate Secretary

Dr. Miguel A. Lopez-Lago Ph.D.

Chief Scientific Officer

FAQs

What is Briacell Therapeutics Corp share price today?

Briacell Therapeutics Corp share price today is $0.15 as on at the close of the market. Briacell Therapeutics Corp share today touched a day high of $0.15 and a low of $0.14.

What is the 52 week high and 52 week low for Briacell Therapeutics Corp share?

Briacell Therapeutics Corp share touched a 52 week high of $1.52 on and a 52 week low of $0.06 on . Briacell Therapeutics Corp stock price today i.e. is closed at $0.15,which is 90.10% down from its 52 week high and 172.23% up from its 52 week low.

How to invest in Briacell Therapeutics Corp Stock (BCTXZ) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Briacell Therapeutics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Briacell Therapeutics Corp Shares that will get you 10.0000 shares as per Briacell Therapeutics Corp share price of $0.15 per share as on April 11, 2026 at 1:28 am IST.

What is the minimum amount required to buy Briacell Therapeutics Corp Stock (BCTXZ) from India?

Indian investors can start investing in Briacell Therapeutics Corp (BCTXZ) shares with as little as ₹93.048 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.48 in Briacell Therapeutics Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Briacell Therapeutics Corp share’s latest price of $0.15 as on April 11, 2026 at 1:28 am IST, you will get 66.6667 shares of Briacell Therapeutics Corp. Learn more about fractional shares .